- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07655765
The Effect of Breastfeeding Education Using the Pecha Kucha Technique on Breastfeeding Self-Efficacy and Breastfeeding Success in the Early Postpartum Period: A Randomized Controlled Trial
June 13, 2026 updated by: YASEMİN AYDIN KARTAL, Saglik Bilimleri Universitesi
Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns.
Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal morbidity and mortality rates.
The Pecha Kucha presentation technique keeps presentations concise and dynamic, creating a fast-paced, light, and engaging experience.
It minimizes distractions and maximizes engagement.
Because there is no text to read in the Pecha Kucha technique, presenters are required to be more prepared and strive to create a coherent narrative, resulting in a flawless narrative.
Thus, the aim is to ensure the success and effectiveness of breastfeeding education with this technique, and ultimately, to promote breastfeeding education using the Pecha Kucha technique to healthcare professionals.
The population of this randomized, controlled experimental study consists of primiparous postpartum women who gave birth in the Obstetrics Department of the Physical Therapy Annex Building of the Gaziosmanpaşa Training and Research Hospital at the University of Health Sciences.
A power analysis was conducted using the G*Power package program, Version 3.1.9.4, to determine the sample size of the study.
Because no similar research was found in the literature, Cohen's medium effect size was chosen as the effect size, anticipating that tests assessing the difference between two independent groups would be used when examining the differences in variables between the control and intervention groups.
Accordingly, with 64 participants in the control group and 64 in the intervention group, a power of 80% was calculated at a significance level of 0.5 (medium) effect size and 0.05, and a minimum sample size of 128 was determined.
The study, planned using an experimental design, is planned to be conducted on two groups: an intervention and a control group.
Within the scope of the study, pretest data will be collected by administering the Breastfeeding Self-Efficacy Scale and the LATCH Breastfeeding Diagnostic and Assessment Scale, along with an introductory information form, to postpartum women who agree to participate in the study.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
128
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yasemin, AYDIN KARTAL, Prof. Dr.
- Phone Number: (0216) 777 87 77
- Email: yasemin.aydin@sbu.edu.tr
Study Contact Backup
- Name: Merve N KAYADUMAN, Midwife
- Phone Number: (0216) 777 87 77
- Email: merve.kydmn@gmail.com
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Sağlık Bilimleri Üniversitesi, İstanbul,
-
Contact:
- Merve N KAYADUMAN, Midwife
- Phone Number: (0216) 777 87 77
- Email: merve.kydmn@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- - Being primiparous
- Having a full-term, singleton birth
- Having a healthy newborn
- Having a spontaneous vaginal birth
Exclusion Criteria:
- Being multiparous (having given birth more than once)
- Having given birth preterm or postterm
- Having a mother or newborn with health problems
- Having had a multiple pregnancy
- Having had a cesarean section
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
Mothers in the intervention group will receive breastfeeding training using the Pecha Kucha presentation technique at the first hour postpartum
|
Training will be provided using training material consisting of 20 slides, each lasting 20 seconds, prepared using the 'Pecha Kucha' technique, for a total duration of 6 minutes and 20 seconds.
|
|
No Intervention: control group
Standard breastfeeding education, as part of the routine postpartum care practices of the Ministry of Health, will be given to the puerperal women in the control group at the first hour postpartum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
introductory information form
Time Frame: 10 minitus
|
This form, created by researchers based on literature, includes questions about the participants' age, high school graduation, their self-sufficiency against disasters, etc.
|
10 minitus
|
|
Breastfeeding Self-Efficacy Scale
Time Frame: 10 minutes
|
The Breastfeeding Self-Efficacy Scale was developed by the National Institutes of Health (NIH) to assess mothers' breastfeeding self-efficacy levels.
The initial form consisted of 33 items.
In 2003, the scale was shortened to a 14-item version.Dennis recommends using the short form.
The Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert-type scale (1 = Not at all confident and 5 = Always confident).
The lowest possible score is 14, and the highest is 70.
As the score increases, breastfeeding self-efficacy also increases.
The validity and reliability of the scale in Turkey were conducted by Aluş Tokat, Okumus, and Dennis (2010).
The scale is a 5-point Likert-type scale, with scores ranging from Not at all confident (1 point) to Always confident (5 points).
The minimum possible score is 14, and the maximum score is 70.
There is no cut-off point for the scale.
A higher score indicates higher breastfeeding self-efficacy.
The Cronbach's alpha for the scale was found to be0.87
|
10 minutes
|
|
Latch Breastfeeding Diagnostic and Assessment Scale
Time Frame: 10 minutes
|
The LATCH Breastfeeding Diagnostic Measurement Tool was developed by Jensen and colleagues (1994).
LATCH is a diagnostic tool created by simulating the Apgar scoring system in terms of its scoring method.
It is a quick and easy scale to evaluate (Jensen, Wallace 1994).
The Turkish validation of the tool was conducted by Demirhan in 1997, Koyun in 2001, and Yenal and Okumuş in 2003, and it was recommended as a reliable tool.
The lowest score obtained from the scale is 0, and the highest is 10.
A higher score indicates breastfeeding success.
The Cronbach's alpha value of the LATCH Breastfeeding Diagnostic Measurement Tool was found to be 0.95 by Yenal and Okumuş.
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 13, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
June 13, 2026
First Submitted That Met QC Criteria
June 13, 2026
First Posted (Actual)
June 18, 2026
Study Record Updates
Last Update Posted (Actual)
June 18, 2026
Last Update Submitted That Met QC Criteria
June 13, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBU-AYDINKARTAL-KAYADUMAN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pecha Kuka
-
Firat UniversityCompletedPalliative Care | Pecha KukaTurkey
Clinical Trials on pecha kucha
-
Firat UniversityCompletedPalliative Care | Pecha KukaTurkey
-
Saglik Bilimleri UniversitesiCompleted
-
Tokat Gaziosmanpasa UniversityCompletedMenopause | Education | Women's HealthTurkey (Türkiye)
-
Ataturk UniversityCompletedHemodialysis PatientsTurkey (Türkiye)
-
Ataturk UniversityCompleted
-
MAİDE YEŞİLYURTAksaray UniversityRecruiting
-
MAİDE YEŞİLYURTAksaray UniversityCompleted
-
Büşra Ceren DEMİREL YILDIZNot yet recruitingHemodialysis | Chronic Kidney Disease
-
Istanbul Sabahattin Zaim UniversityCompletedPsychological Resilience | Posttraumatic Growth | Breast Cancer PatientsTurkey
-
Necmettin Erbakan UniversityCompletedInjection SiteTurkey